ClinicalTrials.gg
RecruitingNCT06148467RT-CHASERSUpdated Sep 16, 2026

Reverse Trigger Phenotypification and Response to Ventilatory Adjustments

An observational study in Reverse Trigger, Acute Respiratory Distress Syndrome and Mechanical Ventilation, sponsored by Hospital Civil de Guadalajara. Recruiting at 1 site in Mexico. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Hospital Civil de Guadalajara · Observational

From the registry’s dates

  • Started Nov 2023; still recruiting 2 years 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
130
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The goal of this prospective observational study is to describe the incidence of reverse trigger (RT) in mechanically ventilated patients with diagnosis of acute respiratory distress syndrome (ARDS).

The main questions it aims to answer are:

  • Real incidence of RT based on continuous monitoring
  • The response to mechanical ventilatiory adjustments Participants will be included as soon as neuromuscular blockers (NMB)/sedation is stopped or in case of spontaneous respiratory efforts detection, whatever happens first. Continuous monitoring will be performed by esophageal manometry until switch to a pressure support (spontaneous) mode, restart of deep sedation/neuromuscular blockers by medical indication, or death.

In order to allow detection of possible RT in patients with ongoing sedation/NMB, mechanical ventilator waveforms will be screened every 1-2 hours by investigators and critical care physicians with at least 1 year of specific training in detection of dyssynchronies.

Read the detailed description

Measurements:

An esophageal catheter for manometry will be placed as usual practice with confirmation of adequate position with the Baydur's occlusion test before recordings. An independent flow sensor and pressure transducer will be placed and connected to a laptop computer to obtain real-time monitoring along with continuous recordings, which then will be off-line analyzed by two experts, for confirmation of RT and characterization.

Data collection:

Main cause of the acute respiratory failure and days on mechanical ventilation until enrollment will be collected as well as demographic characteristics, including APACHE II, SOFA and the previous requirement of prone positioning therapy.

At identification of the RT, drugs for sedation and analgesia, time from initiation of mechanical ventilation to RT identification and blood gas analysis will be recorded. Ventilatory settings will also be collected, including the control variable of the ventilatory mode (volume or pressure), respiratory rate, received tidal volume in ml/kg of predicted body weight, maximum inspiratory flow, ratio of partial arterial oxygen pressure (pO2) to fraction of inspired oxygen (FiO2), driving pressure and (positive end-expiratory pressure (PEEP). Data about esophageal pressure related to RT will also be recorded, including the magnitude of pressure swing, phase angle, coefficient of variation, RT phenotype, entrainment ratio and the presence of breath stacking.

Patient-centered outcomes including length of mechanical ventilation, intensive care and hospital length of stay, and mortality will be followed-up until 60 days.

02

Conditions studied

  • Reverse Trigger
  • Acute Respiratory Distress Syndrome
  • Mechanical Ventilation

Keywords

  • Reverse trigger
  • Acute Respiratory Distress Syndrome
  • Dyssynchony
  • Mechanical Ventilation
03

In context

Respiratory Distress Syndrome

1,387 studies on the registry are indexed under Respiratory Distress Syndrome; 283 are open to participants now.

This study's planned enrollment of 130 is above the median of 100 across 475 observational studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

Hospital Civil de Guadalajara is the lead sponsor of 41 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Mechanically ventilated patients with acute respiratory distress syndrome.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of ARDS according to the Berlin criteria and added New Global Definition 2023
  • Mechanical ventilation

Exclusion criteria

Exclusion Criteria:

  • \<18 years
  • Tracheostomy status
  • Pneumothorax
  • Tube thoracostomy with air leaks
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
130 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Incidence of reverse trigger

    Proportion of patients who developed reverse trigger

    Time frame: 60 days

Secondary outcomes

  1. Days of mechanical ventilation

    Days of mechanical ventilation

    Time frame: 60 days

  2. ICU length of stay

    Days from ICU admission to discharge to wards

    Time frame: 60 days

  3. Mortality

    Rate of deceased patients in percentage

    Time frame: 60 days

Other outcomes

  1. Duration of RT

    Total time of presence of RT

    Time frame: 60 days

  2. Phenotypes of RT

    Rate of the different phenotypes according to cycle initiation and termination of patient's respiratory effort

    Time frame: 60 days

  3. Intensity of breathing efforts

    Intensity of respiratory efforts as measured by esophageal manometry

    Time frame: 60 days

  4. Association with severity

    Association of RT with lung disease severity as measured by pO2:FiO2 ratio

    Time frame: 60 days

  5. Response to ventilatory adjustments

    Change in RT characteristics after changing ventilatory settings

    Time frame: 60 days

07

Study locations

1 of 1 sites recruiting
  • Hospital Civil Fray Antonio Alcalde
    Guadalajara, 44280, Mexico
    Recruiting
    • Miguel Ibarra-Estrada, MD · Contactdrmiguelibarra@hotmail.com · 3317593502
    • Guadalupe Aguirre-Avalos, MD · Contactguadalupe.aavalos@academicos.udg.mx
    • Quetzalcóatl Chávez-Peña, MD · Sub investigator
    • Arnulfo López-Pulgarín, MD · Sub investigator
    • Guadalupe Aguirre-Avalos, PhD · Sub investigator
    • Miguel Ibarra-Estrada, MD · Principal investigator
    • David Hernández-Lugo, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2023 (actual). Primary completion is estimated for Dec 2027, 49 months after the start.

Of 225 non-industry observational studies under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 49 months is above that.

Counting every sponsor, half of 231 studies reached it within 24 months; a quarter within 12 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 19, 2023
First posted
Nov 28, 2023
StartActual
Nov 17, 2023
Primary completionEst.
Dec 31, 2027
CompletionEst.
Feb 1, 2028
Last update
Sep 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06148467
Lead sponsor
Hospital Civil de Guadalajara
Responsible party
Miguel Á Ibarra-Estrada (MD, Hospital Civil de Guadalajara) — Principal investigator
First posted
Nov 28, 2023
Start date
Nov 17, 2023
Primary completion
Dec 31, 2027 (estimated)
Completion
Feb 1, 2028 (estimated)
Last update
Sep 16, 2026

Study contacts

Miguel Ibarra-Estrada, MD
Contact
drmiguelibarra@hotmail.com
+523317593502
Miguel Ibarra Estrada, MD
principal investigator · Hospital Civil Fray Antonio Alcalde

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion